Effective treatment of severe COVID-19 patients with tocilizumab
Significance In patients with coronavirus disease 2019, a large number of T lymphocytes and mononuclear macrophages are activated, producing cytokines such as interleukin-6 (IL-...
Publications
3 shownDiagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19
Abstract The role of clinical laboratory data in the differential diagnosis of the severe forms of COVID‐19 has not been definitely established. The aim of this study was to loo...
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Abstract Objective To assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (co...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 4,891
- Institution
- Fuyang Second People's Hospital
External Links
Identifiers
- ORCID
- 0000-0001-6646-8085
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.